| 000 | 01562 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516054227.0 | ||
| 264 | 0 | _c20120111 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1935-2735 | ||
| 024 | 7 |
_a10.1371/journal.pntd.0001316 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDivanovic, Senad | |
| 245 | 0 | 0 |
_aTherapeutic enhancement of protective immunity during experimental leishmaniasis. _h[electronic resource] |
| 260 |
_bPLoS neglected tropical diseases _cSep 2011 |
||
| 300 |
_ae1316 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimony Sodium Gluconate _xadministration & dosage |
| 650 | 0 | 4 |
_aAntiprotozoal Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBiological Products _xadministration & dosage |
| 650 | 0 | 4 |
_aDiphtheria Toxin _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xadministration & dosage |
| 650 | 0 | 4 |
_aInterleukin-2 _xadministration & dosage |
| 650 | 0 | 4 |
_aLeishmaniasis, Cutaneous _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTrompette, Aurelien | |
| 700 | 1 | _aAshworth, Jamie I | |
| 700 | 1 | _aRao, Marepalli B | |
| 700 | 1 | _aKarp, Christopher L | |
| 773 | 0 |
_tPLoS neglected tropical diseases _gvol. 5 _gno. 9 _gp. e1316 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pntd.0001316 _zAvailable from publisher's website |
| 999 |
_c21149321 _d21149321 |
||